DePuy Orthopaedics, Inc recently announced a recall of two DePuy ASR hip implants. This comes after a large amount of hip failures and revision surgeries were reported.
DePuy Orthopaedics, Inc. is a subsidiary of Johnson & Johnson. Included in this recall are about 93,000 DePuy ASR XL Acetabular System Implants and DePuy ASR Hip Resurfacing System Implants.
Recent studies and data indicate that those who receive the ASR Hip System experience pain and other symptoms that lead to a second hip replacement surgery called a revision surgery. Approximately 12 % of patients (1 in eight) who have received the ASR resurfacing device and 13% of patients (1 in eight) who had received the ASR total hip replacement needed to have a second surgery, a revision surgery.
The ASR hip implant failure rate has been steadily growing since 2007 when 100 cases were reported. This grew to 200 cases in 2008 and 300 cases in 2009. In December 2009 these high rates could no longer be ignored and DePuy took the hip replacement device off the Australian market. Although problems with the implant had been apparent for more than two years, DePuy claimed the product was being removed due to slow sales. It was not until March 2010, almost three years after statements of failure were first reported, that DePuy informed physicians of the failures of the ASR hip replacement.
The DePuy companys says, “this recall means additional testing and monitoring may be necessary to ensure your hip implant is functioning well.” However, there are some cases where additional surgery is necessary.
If you or a loved one has received the DePuy ASR XL Acetabular System or DePuy ASR Hip Resurfacing System and have experienced some type of hip pain, additional hip surgery, or some type of failure with your hip replacement, you may want to contact CSS Firm for a free case evaluation and consultation. Our experienced team of hip implant lawyers will work closely with you and see to it that you are compensated for your injuries.
Other Depuy ASR Hip Implant News
Broadspire manages limited reimbursement programs for recalled DePuy and Stryker hip implants—but these benefits are not guaranteed and may impact your legal rights. Consult an attorney before proceeding.
DePuy has announced a second round of ASR hip implant settlements for patients with revision surgeries through January 2015. Learn who qualifies and what this new proposal could mean for you.
DePuy has proposed a major settlement for U.S. patients who underwent revision surgery due to recalled ASR hip implants, potentially offering compensation through base and supplemental award funds.
A California jury awarded $8.38 million to a DePuy ASR hip implant victim, finding the device was defectively designed—marking a pivotal outcome in the first jury trial of its kind.
Federal prosecutors are investigating Johnson & Johnson’s marketing of recalled hip implants amid growing concerns over device failures and the company’s prior legal troubles.
Over 10,000 DePuy ASR hip implant lawsuits have been filed nationwide, with multiple Bellwether trials underway. Learn where cases stand and what this could mean for affected patients.
